TerSera Therapeutics LLC recalls Zoladex (goserelin) implant
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
- Products
-
- Zoladex (goserelin) implant
- Company
- TerSera Therapeutics LLC
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 296 cartons
- About this recall
- Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.